SCHEDULE OF WARRANT ACTIVITY (Details) - Warrant [Member] - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Warrants outstanding, Beginning | 37,083 | 1,154 |
Warrants Weighted Average Exercise Price, Beginning | $ 19.52 | $ 8.80 |
Warrants Aggregate Intrinsic Value, Beginning | ||
Warrants Issued | 311,668 | 212,548 |
Warrants Weighted Average Exercise Price, Issued | $ 6.00 | $ 11.55 |
Warrants Aggregate Intrinsic Value, Issued | ||
Warrants Exercised | 46,786 | |
Warrants Weighted Average Exercise Price, Exercised | $ 10.00 | |
Warrants Expired | 25,208 | 129,832 |
Warrants Weighted Average Exercise Price, Expired | $ 24.00 | $ 9.82 |
Warrants outstanding, Beginning | 323,543 | 37,083 |
Warrants Weighted Average Exercise Price, End | $ 6.15 | $ 19.52 |
Warrants Aggregate Intrinsic Value, End |
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non options weighted average exercise price per share. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non options weighted average exercise price per share exercised No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non options weighted average exercise price per share expired No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non options weighted average exercise price per share issued No definition available.
|
X | ||||||||||
- Definition Sharebased Compensation Arrangement by Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Issued No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|